Funding Trigger Date

Funding Trigger Date. Means the date on which the Company notifies the Investors that a patient enrolled in any treatment arm of the Company's Phase 3 study (VIKTORIA-1) has received their first dose of treatment at a clinical site located in the United States, provided that such date must occur on or before December 31, 2022.